Ernakulam Court Summons Ramdev, Balkrishna In Drug Promotion Case

THIRUVANANTHAPURAM:  A court in Ernakulam has directed Baba Ramdev and Acharya Balkrishna of Divya Pharmacy to be present in the court in cases filed by the Drugs Control Department. The Judicial First Class Magistrate Court in Kakkanad issued two separate orders in connection with the illegal drug promotions.

The department accused both Ramdev and Acharya of violating Section 3(d) of Drugs and Magic Remedies (Objectionable Advertisements) Act in these cases. The court issued summons to the accused in one case on January 30 and issued directions for the production of the accused in another case on February 17 next year. Besides, the Additional Chief Judicial Magistrate in Thiruvananthapuram also issued notice to the same accused in another case filed by the department. The case is posted for November 21.

The Drugs Control Department has filed a total of 10 cases against Ramdev-promoted Divya Pharmacy for publishing misleading advertisements in various courts in Kozhikode (4 cases), Palakkad (3 cases), Ernakulam (2 cases) and Thiruvananthapuram (1 case).

The cases have been registered for violation of Section 3(d) of Drugs and Magic Remedies (Objectionable advertisement) Act 1954. Under the law, cure of 54 diseases listed in the schedule should not be advertised.

The state’s drugs control department became the first drug licensing agency in the country to file a case against Patanjali Ayurved in a court for publishing misleading advertisements in April.

The department found that Patanjali’s Divya Pharmacy advertised pharmaceutical products for diseases, in which the cure should not be advertised, in more than 30 instances. The cases were initiated based on a complaint filed by Dr Babu K V, a health activist from Kannur.

Related Posts

  • Pharma
  • May 16, 2025
  • 100 views
Trump targets Big Pharma with drug price order; Indian generics seen gaining edge

US President Donald Trump’s move to slash prescription drug prices by tying them to rates in countries such as the UK and Germany may rattle multinational pharmaceutical giants, but it…

  • Pharma
  • May 16, 2025
  • 96 views
Emcutix and Mantra Pharma Introduce Ureaderm: Advanced Urea-Based Moisturizers for Indian Skin

Emcutix Biopharmaceuticals Ltd in partnership with Canada-based Mantra Pharma Inc—both subsidiaries of Emcure Pharmaceuticals Ltd—has launched Ureaderm 10% and 20%, a new range of urea-based moisturizers designed to address severe dryness…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Trump targets Big Pharma with drug price order; Indian generics seen gaining edge

Trump targets Big Pharma with drug price order; Indian generics seen gaining edge

Emcutix and Mantra Pharma Introduce Ureaderm: Advanced Urea-Based Moisturizers for Indian Skin

Emcutix and Mantra Pharma Introduce Ureaderm: Advanced Urea-Based Moisturizers for Indian Skin

DCA seizes syrup stocks over misleading fever cure claim

DCA seizes syrup stocks over misleading fever cure claim

Mankind Pharma Faces Rs 341.86 Cr Tax Demand

Mankind Pharma Faces Rs 341.86 Cr Tax Demand

Piramal Pharma stock falls 5% after Q4 results; check key numbers here

Piramal Pharma stock falls 5% after Q4 results; check key numbers here

Biolumpivaxin: Bharat Biotech launches new vaccine against lumpy skin disease

Biolumpivaxin: Bharat Biotech launches new vaccine against lumpy skin disease